@article {Von Woon2022.03.30.22273165, author = {Ee Von Woon and Victoria Male}, title = {Effect of COVID-19 vaccination on menstrual periods in a prospectively recruited cohort}, elocation-id = {2022.03.30.22273165}, year = {2022}, doi = {10.1101/2022.03.30.22273165}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {COVID-19 vaccination protects against the potentially serious consequences of SARS-CoV2 infection, but some people have been hesitant to receive the vaccine because of reports that it could affect menstrual bleeding. To determine whether this occurs, we prospectively recruited a cohort of 79 individuals, each of whom recorded details of at least three consecutive menstrual cycles, during which time they each received at least one dose of COVID-19 vaccine. We find that either dose of the COVID-19 vaccine is associated with a delay to the subsequent period in spontaneously cycling participants (2.3 days after dose 1; 1.3 days after dose 2) but this change rapidly reverses. No change to timing was detected in those on hormonal contraception. We detected no change in menstrual flow associated with either dose of the vaccine, in either spontaneously cycling participants or those on hormonal contraception. We detected no association between menstrual changes and other commonly-reported side effects of vaccination, such as sore arm, fever and fatigue.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any specific funding. The investigators were funded by the preterm birth research charity Borne.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Governance and Integrity Team at Imperial College London gave ethical approval for this work (study number 21IC6988).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCleaned, fully anonymised data, together with our analysis files, are available from the Open Science Framework at https://osf.io/upbyg/ https://osf.io/upbyg/}, URL = {https://www.medrxiv.org/content/early/2022/03/30/2022.03.30.22273165}, eprint = {https://www.medrxiv.org/content/early/2022/03/30/2022.03.30.22273165.full.pdf}, journal = {medRxiv} }